Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 1
Out of 4,818 analysts
131
Total ratings
65.22%
Success rate
268.78%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Overweight | $280 → $260 | $196.52 | +32.30% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $228.31 | +27.02% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $10.10 | +117.93% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $175.87 | +5.19% | 1 | Dec 10, 2024 | |
| QDEL QuidelOrtho | Initiates: Hold | $43 | $27.77 | +54.84% | 5 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $58.29 | +45.82% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $43 → $56 | $43.06 | +29.17% | 5 | Dec 10, 2024 | |
| WAT Waters | Upgrades: Buy | $355 → $415 | $341.29 | +21.60% | 7 | Oct 8, 2024 | |
| TWST Twist Bioscience | Maintains: Underweight | $28 → $35 | $40.14 | -12.81% | 3 | Aug 5, 2024 | |
| RVTY Revvity | Maintains: Hold | $115 → $125 | $95.21 | +31.29% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $8.31 | +188.81% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.14 | +250.88% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.71 | +320.76% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $154.48 | -8.08% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $47.33 | -32.39% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $77.60 | +48.20% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $7.36 | +171.74% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $426.66 | +52.35% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $1,230 → $1,250 | $1,067.19 | +17.13% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $11.31 | -20.42% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.32 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.01 | +498.50% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.58 | +975.27% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.05 | +654.10% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $115.89 | +236.54% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $107.02 | +40.16% | 7 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $1.27 | +1,711.02% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.03 | +494.06% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $508.13 | -60.64% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $15.98 | +50.19% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $13.70 | +228.47% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $160 | $0.56 | +28,471.43% | 4 | Sep 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $145.40 | -51.86% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $150.68 | -20.36% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.54 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $38.88 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $14.50 | +279.31% | 1 | Jul 19, 2016 |
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $196.52
Upside: +32.30%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $228.31
Upside: +27.02%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $10.10
Upside: +117.93%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $175.87
Upside: +5.19%
QuidelOrtho
Dec 10, 2024
Initiates: Hold
Price Target: $43
Current: $27.77
Upside: +54.84%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $58.29
Upside: +45.82%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $43.06
Upside: +29.17%
Waters
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $341.29
Upside: +21.60%
Twist Bioscience
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $40.14
Upside: -12.81%
Revvity
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $95.21
Upside: +31.29%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $8.31
Upside: +188.81%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.14
Upside: +250.88%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.71
Upside: +320.76%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $154.48
Upside: -8.08%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $47.33
Upside: -32.39%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $77.60
Upside: +48.20%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $7.36
Upside: +171.74%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $426.66
Upside: +52.35%
Jun 3, 2024
Assumes: Underperform
Price Target: $1,230 → $1,250
Current: $1,067.19
Upside: +17.13%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $11.31
Upside: -20.42%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.32
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.01
Upside: +498.50%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.58
Upside: +975.27%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.05
Upside: +654.10%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $115.89
Upside: +236.54%
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $107.02
Upside: +40.16%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $1.27
Upside: +1,711.02%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.03
Upside: +494.06%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $508.13
Upside: -60.64%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $15.98
Upside: +50.19%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $13.70
Upside: +228.47%
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $0.56
Upside: +28,471.43%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $145.40
Upside: -51.86%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $150.68
Upside: -20.36%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.54
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $38.88
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $14.50
Upside: +279.31%